Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2021

Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer

1 ASU - Ain Shams University
2 UC San Francisco - University of California [San Francisco]
3 Clinical Oncology Department, Kasr Alainy School of Medicine, Cairo University, Giza 12613
4 Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC 20007
5 Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030
6 Breast Center, Clinique de Genolier, 1272 Genolier
7 Department of Hematology & Oncology, Mayo Clinic, Jacksonville, FL 32224
8 University of Washington [Seattle]
9 IMoST - Imagerie Moléculaire et Stratégies Théranostiques
10 UNICANCER/CJP - Centre Jean Perrin [Clermont-Ferrand]
11 Unipd - Università degli Studi di Padova = University of Padua
12 Department of Internal Medicine, Division of Hematology Oncology, American University of Beirut Medical Center, Beirut 1107 2020
13 Subang Jaya Medical Centre, Kuala Lumpur 47500
14 USJ - Université Saint-Joseph de Beyrouth
15 UA - University of Antwerp
16 Clinical oncology Department, Menoufia University, Shebin Elkom 51132
17 Department of Surgery, Surgical Oncology Division, Cedars-Sinai Medical Center, Los Angeles, CA 90048
18 Department of Breast Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030
19 CRSA - Centre de Recherche Saint-Antoine
20 Marmara University [Kadıköy - İstanbul]
21 Federal State Budgetary Institution “NN Blokhin National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation, 127994 Moscow
22 Surgical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030
23 UNIMI - Università degli Studi di Milano = University of Milan
24 Al Hyatt Oncology Practice, Amman 11183
25 Department of Clinical Oncology, Alexandria School of Medicine, Alexandria 21131
26 Russian Association of Oncological Mammology, Department of Breast Tumours of Federal State Budgetary Institution “Petrov Research Institute of Oncology”, 197758 Saint Petersburg
27 Western University of Health Sciences
28 Vice President of Galala University, Galala University, Suez 435611
29 Oncology Department, Alfaisal university, Alhabib Hospital, Riyad 11533
30 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032
31 University of Adelaide
32 Biomedical Genomics & Oncogenetics Research Laboratory, Faculty of Sciences and Techniques of Tangier, Abdel Malek Essaadi University, Tangier 90000
Joseph Gligorov
Adel Aref
  • Fonction : Auteur

Résumé

Background: The management of patients with triple-negative breast cancer (TNBC) is challenging with several controversies and unmet needs. During the 12th Breast-Gynaecological & Immuno-oncology International Cancer Conference (BGICC) Egypt, 2020, a panel of 35 breast cancer experts from 13 countries voted on consensus guidelines for the clinical management of TNBC. The consensus was subsequently updated based on the most recent data evolved lately. Methods: A consensus conference approach adapted from the American Society of Clinical Oncology (ASCO) was utilized. The panellists voted anonymously on each question, and a consensus was achieved when ≥75% of voters selected an answer. The final consensus was later circulated to the panellists for critical revision of important intellectual content. Results and conclusion: These recommendations represent the available clinical evidence and expert opinion when evidence is scarce. The percentage of the consensus votes, levels of evidence and grades of recommendation are presented for each statement. The consensus covered all the aspects of TNBC management starting from defining TNBC to the management of metastatic disease and highlighted the rapidly evolving landscape in this field. Consensus was reached in 70% of the statements (35/50). In addition, areas of warranted research were identified to guide future prospective clinical trials.
Fichier principal
Vignette du fichier
cancers-13-02262-v3.pdf (959.48 Ko) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03249497 , version 1 (09-06-2021)

Licence

Identifiants

Citer

Hesham Elghazaly, Hope Rugo, Hamdy Azim, Sandra Swain, Banu Arun, et al.. Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer. Cancers, 2021, 13 (9), pp.2262. ⟨10.3390/cancers13092262⟩. ⟨hal-03249497⟩
160 Consultations
115 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More